Stories from MedEsthetics

Business Education for Medical Practitioners
Visit us at medestheticsmagazine.com
Thursday, April 2, 2015 - 12:55
Deck: Byline: Main Image: April is Rosacea Awareness month, and the National Rosacea Society (NRS) is reminding providers that they offer a plethora of patient education materials on their website. One of the Society’s primary goals is to promote the early recognition of symptoms—according to an NRS survey of 1,459 rosacea patients, 47% had never heard of rosacea prior to their diagnosis, and 95% had little or no knowledge about its signs and symptoms.No, don't share this with BeautyEtcArticles: Skin CareNewsArticle free tagging: National Rosacea Societypatient...
http://medestheticsmag.com/rosacea-awareness-month
Thursday, March 26, 2015 - 13:13
Main Image: At the conclusion of the American Academy of Dermatology (AAD) 73rd Annual Meeting in San Francisco, Mark G. Lebwohl, MD, took office as the Academy’s new president. He will hold the office for one year. No, don't share this with BeautyEtcArticles: NewsArticle free tagging: American Academy of DermatologyMark G. Lebwohl MD
http://medestheticsmag.com/new-aad-president-takes-office
Thursday, March 26, 2015 - 13:10
Main Image: Merz Aesthetics has announced positive results from a post-market, parallel group clinical trial to evaluate the efficacy of Xeomin (incobotulinumtoxinA) in the treatment of moderate to severe glabellar facial lines when compared to Botox Cosmetic (onabotulinumtoxinA, Allergan). The trial met its primary efficacy endpoint, defined as ≥ 1-point improvement from baseline on the Facial Wrinkle Scale (FWS) at maximum frown one month after a single treatment.No, don't share this with BeautyEtcArticles: Skin CareNewsArticle free tagging: XeominMerz Aestheticsbotulinumtoxin
http://medestheticsmag.com/xeomin-meets-primary-endpoint-parallel-clinical-study
Thursday, March 26, 2015 - 12:46
Deck: Byline: Biotechnology company Signum Dermalogix has entered into an agreement with Dermata Therapeutics, a specialty pharmaceutical company based in San Diego, to develop SIG990, an isoprenylcysteine (IPC) analog that modulates toll-like receptor (TLR) and G-protein signaling, for the treatment of patients with rosacea. No, don't share this with BeautyEtcArticle free tagging: Signum DermalogixDermataSIG990Articles: Skin CareNews
http://medestheticsmag.com/signum-dermalogix-and-dermata-develop-topical-rosacea-treatment
Thursday, March 26, 2015 - 12:43
Deck: Byline: Alma Lasers launched its new Soprano ICE Multi-Platform laser for hair removal at the American Academy of Dermatology (AAD) 73rd Annual Meeting. The device combines an alexandrite 755nm laser with a 1064nm diode laser to comfortably treat a wide range of hair types and skin tones. The multi-laser, multi-technology approach also provides lower maintenance for providers, featuring several modules that decrease treatment times and allow for more versatile treatments. No, don't share this with BeautyEtcArticle free tagging: Alma LasersSoprano ICE Multi-Platform...
http://medestheticsmag.com/alma-lasers-launches-new-ice-platform
Thursday, March 19, 2015 - 16:51
Deck: Byline: Main Image: The U.S. Food & Drug Administration has approved Radiesse (+) with integral 0.3% lidocaine (Merz Aesthetics) for subdermal implantation to correct moderate to severe wrinkles and folds. In a clinical study, 101 patients received Radiesse on one side of the face and Radiesse (+) on the other side of the face. Patients rated their pain on a scale of 0 to 10 (0 = no pain and 10 = very severe pain). Immediately after injection, patients rated their pain about 6.7 for the side of the face injected with Radiesse compared to about 2.3 for the side treated...
http://medestheticsmag.com/fda-approves-radiesse
Thursday, March 19, 2015 - 16:48
Deck: Byline: Actavis has completed its acquisition of Allergan in a cash and equity transaction valued at approximately $70.5 billion. The merger makes Actavis one of the world’s top 10 pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than $23 billion anticipated in 2015. The company now has six franchises, including those in eye care, neurosciences/CNS and medical aesthetics/dermatology/plastic surgery, as well as a portfolio of world-renowned brands including BOTOX, RESTASIS, JUVEDERM, NAMENDA XR, LINZESS and Lo Loestrin Fe.No, don't...
http://medestheticsmag.com/actavis-acquires-allergan
Thursday, March 19, 2015 - 16:46
Deck: Byline: In an effort to accelerate the adoption of Watson cognitive computing in health care, IBM has invested in EHR provider, Modernizing Medicine. The investment caps $20 million in Series D funding secured by Modernizing Medicine, raising its overall funding total to $49 million. No, don't share this with BeautyEtcArticle free tagging: IBMWatsonModernizing MedicineArticles: News
http://medestheticsmag.com/ibm-invests-modernizing-medicine
Monday, March 16, 2015 - 12:57
Deck: New sunscreen actives may soon hit the U.S., but several consumer protection issues remain unresolved. Byline: By Linda W. LewisMain Image: There is something new under the sun! Late last year Congress enacted the Sunscreen Innovation Act, which the president signed into law on November 24. The Act amends the U.S. Food and Drug Administration’s time and extent application (TEA) program for sunscreen actives and imposes time limits on the ingredient review process. The TEA, finalized by the FDA in 2002, permits companies to apply for expedited approval for sunscreen...
http://medestheticsmag.com/spotlight-sun-protection
Monday, March 16, 2015 - 12:45
Deck: Practitioners share their protocols for finding high-quality employment candidates.Byline: By Laura BelizMain Image: Attracting a qualified and hard-working prospective employee involves more than just putting an ad on a website. The key to finding the ideal candidate for your practice is to use all of the resources available, including existing staff, industry contacts and job boards. On the following pages, practice owners share their strategies for recruiting top-notch personnel who will support practice success and provide care that keeps patients coming back. No, don...
http://medestheticsmag.com/recruitment-strategies
Monday, March 16, 2015 - 12:32
Deck: Cheryl M. Burgess, MD, has gained national acclaim for her work in clinical and cosmetic dermatology.Byline: By Maryann HammersMain Image: When she was a medical student at the Howard University College of Medicine, Cheryl M. Burgess, MD, landed a summer job at the National Institutes of Health Department of Dermatology as part of its Public Health Service. Two others had been offered the same job—and had quickly quit. “It was our job to physically examine and interact with patients who had the most severe, obscure dermatoses,” she says. “These people had disfiguring...
http://medestheticsmag.com/capital-care
Monday, March 16, 2015 - 12:19
Deck: Laser, peel or microdermabrasion? How to select the right resurfacing treatment for your patients.Byline: By Inga HansenMain Image: Removing the top, damaged layers of the epidermis to reveal smoother skin and stimulate the production of collagen is a time-tested rejuvenation procedure recommended by skincare professionals worldwide. But which skin resurfacing procedure is right for which patient? While chemical peels date back to the days of Cleopatra, who is rumored to have bathed in sour milk to keep her complexion youthful, they have since been joined by dermabrasion...
http://medestheticsmag.com/old
Friday, March 13, 2015 - 15:05
Deck: A new annual event aims to foster relationships between dermatologic innovators and investors.Byline: By Linda W. LewisMain Image: Why is it so difficult to bring new dermatologic innovations to market? Perhaps the problem is consolidation, or maybe the culprit is reduced funding for research and development. A discussion of this topic among dermatologists William Ju, MD, William Eaglstein, MD, and Rox Anderson, MD, and health sciences investor Brian Cunningham in 2011 led to the development of Advancing Innovation in Dermatology, a nonprofit organization designed to help...
http://medestheticsmag.com/dermatology-summit
Friday, March 13, 2015 - 14:50
Main Image: Rescue Bio-Rejuvenation Serum with BioJuv YC Complex from Skinprint features a combination of peptides, moisturizers and skin-calming ingredients to reduce inflammation and stimulate the production of new skin cells. The serum evens skin tone and texture, and reduces redness, pore size, fine lines and wrinkles. Contact: 800.234.1308, www.skinprint.com No, don't share this with BeautyEtcArticles: ProductsArticle free tagging: skin careSkinPrintRescue Bio-Rejuvenation Serum
http://medestheticsmag.com/skin-rescue-rejuvenation
Friday, March 13, 2015 - 14:47
Main Image: Spa Shower from Sebamed is a soap-free formula that uses botanical water lily—which has moisture-binding properties that prevent skin from drying out—to rejuvenate skin without stripping its natural barrier. Allantoin soothes the skin while emollients and moisturizers replenish and soften. The mild formula is recommended for sensitive skin and is also hypoallergenic, and paraben- and alkali-free. Contact: 877.228.4646, www.sebamedusa.com. No, don't share this with BeautyEtcArticles: ProductsArticle free tagging: skin careSebamedSpa Shower
http://medestheticsmag.com/soap-free-body-wash
Friday, March 13, 2015 - 14:32
Deck: It’s not enough to make more than you spend—practices must also keep a close eye on cash flow. Byline: By Cheyenne BrinsonMain Image: Managing cash flow is a challenge for all small-business owners. But with proper planning and insight, cash flow crunches can be avoided. Cash flow planning—or forecasting—starts with a budget. A surprising number of practices do not work with budgets, perhaps because the idea of creating one can seem overly complex. Yet budgeting does not need to be an extensive process. Existing practices can look at their historical data and use that to...
http://medestheticsmag.com/managing-cash-flow
Tuesday, March 10, 2015 - 11:26
Deck: Byline: Main Image: Cosmetic practitioners may soon have a new tool designed to noninvasively reduce fat available. The U.S. Food and Drug Administration's (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee voted unanimously on March 9, 2015, to support the approval of KYTHERA Biopharmaceuticals’ fat-burning injectable ATX-101 (deoxycholic acid), indicated to reduce submental fat (double chin) in adults. Although the FDA is not bound by the committee’s vote, it will consider the recommendation as it continues its review of ATX-101.No, don't share this with...
http://medestheticsmag.com/fda-advisory-committee-unanimously-recommends-approval-atx-101
Thursday, March 5, 2015 - 15:01
Deck: Byline: Main Image: Crown Laboratories will be working with Suneva Medical to co-promote ReFissa (tretinoin cream, USP (Emollient) 0.05%), FDA approved and marketed as an adjunctive agent for use in the mitigation of fine wrinkles, mottled hyperpigmentation and tactile roughness of facial skin.No, don't share this with BeautyEtcArticles: NewsArticle free tagging: Retinoidsantiaging skin careRefissaSuneva
http://medestheticsmag.com/crown-laboratories-co-promote-refissa

Pages

Advertisement - Box 1

Advertisement - Box 2

Advertisement - Box 3

Advertisement - Box 4

Advertisement - Box 5

Advertisement - Box 6